REGISTRATION

The 6th ISI is over, but you can still register to get access to the full program and also receive first-hand information about our post-event webinar

Criteria for Registration

Registration for the 6th International Symposium on Immunobiologicals is free of charge and open to both Brazilians and foreigners.
To participate, it is a prerequisite to be a researcher, professional, student or professor in the area of immunobiologicals and related areas, from institutions of production, promotion, technological development of vaccines, biopharmaceuticals or reagents for diagnosis, or from the public health area.

The registration will give the participant access to the virtual platform of the event, with the right to participate in all lectures, visit the exhibition of posters and interact with other participants.

Participation in workshops, mini courses and webinars pre and post event will be made separately, with separate registration forms for each activity, only for participants registered in the 6th ISI.

The organizers may refuse registration to any participant who is not in line with the symposium conduct, or who harms or endangers other participants or the event, at any time, according to their judgment.

6th ISI Schedule

Check the schedule for for the 2022 event

Expand All +
  • May 3rd


  • Sem título

  • Coral da Fiocruz ▪ WHO ▪ PAHO ▪ Brazilian MoH ▪ Fiocruz ▪ Bio-Manguinhos Chair: Akira Homma, Bio-Manguinhos

  • New technologies for accelerating vaccine development and new delivery methods • Adjuvants – Charles Lutsch, Sanofi* • Vaccine development in 100 days – Adam Hacker, CEPI Chair: Sotiris Missailidis, Bio-Manguinhos

  • May 4th







  • Azul
    Sem título

  • Biopharmaceuticals encoded by DNA and RNA • CART Cells to threat cardiac injuries using mRNA, Joel Rurik, University of Pensylvannia* • Next generation lipid nanoparticles technology for extrahepatic delivery of RNA molecules, Jayesh Kulkarn, NanoVation Chair: Patricia Neves, Bio-Manguinhos

  • Management of Biotech Development and Production in the 4th Industrial Revolution • Gabriel Petrus, ICC Brasil • Jair Calixto, Distrito Chair: Artur Couto, Bio-Manguinhos

  • May 5th







  • Azul claro
    Sem título

  • Cancer diagnosis and core demands • Patient Avatars for predicting cancer treatment response, Daniele Ferreira, Invitrocue • Liquid biopsy for cancer treatment follow-up, Anamaria Camargo, Hospital Sirio Libanes Chair: TBD

  • Innovation towards biosimilars: How to accelerate the access to biopharmaceuticals? • Rationality and flexibility in the regulation of biopharmaceuticals, Rodeina Challand B, BioFactura Inc • Are clinical trials phase III necessary? Xavier Fraise, Frapaise Pharma Consulting* Chair: Rosane Cuber, Bio-Manguinhos

  • One Health and preparedness for the next pandemic • Peter Daszak, President, EcoHealth • A. Alonso Aguirre, Colorado State University* • Laura Marin, Joint Programming Iniciative on Antimicrobial Resistance Chair: Maurício Zuma, Bio-Manguinhos

  • ▪ Poster Award Independent Committee ▪ Mauricio Zuma, Bio-Manguinhos Event close-up remarks Akira Homma, Bio-Manguinhos
    Cinza escuro

Sponsors

Partners

Realization